1. Home
  2. BHVN vs UVV Comparison

BHVN vs UVV Comparison

Compare BHVN & UVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$8.96

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Universal Corporation

UVV

Universal Corporation

HOLD

Current Price

$50.95

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHVN
UVV
Founded
2013
1886
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2022
1994

Fundamental Metrics

Financial Performance
Metric
BHVN
UVV
Price
$8.96
$50.95
Analyst Decision
Buy
Analyst Count
14
0
Target Price
$28.85
N/A
AVG Volume (30 Days)
1.9M
161.8K
Earning Date
03-02-2026
02-09-2026
Dividend Yield
N/A
6.36%
EPS Growth
26.08
N/A
EPS
N/A
3.02
Revenue
N/A
$2,922,924,000.00
Revenue This Year
N/A
$0.67
Revenue Next Year
N/A
$0.10
P/E Ratio
N/A
$17.12
Revenue Growth
N/A
7.40
52 Week Low
$7.48
$49.96
52 Week High
$31.18
$67.33

Technical Indicators

Market Signals
Indicator
BHVN
UVV
Relative Strength Index (RSI) 30.23 35.04
Support Level $8.40 $50.00
Resistance Level $15.66 $54.01
Average True Range (ATR) 0.65 0.85
MACD -0.14 -0.12
Stochastic Oscillator 4.26 7.69

Price Performance

Historical Comparison
BHVN
UVV

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About UVV Universal Corporation

Universal Corp is an international leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, Egypt, Philippines, Germany, and Other Countries with majority of revenue from USA.

Share on Social Networks: